Pandelis Banias
Evanston, ILNPI 1558477570
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.2% of the total across 394 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 12.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $3,194 and has fallen 60.6% since, to $1,258 in 2021.
Across 394 payments — averaging $18.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$877
- Boehringer Ingelheim$729
- GSK$648
- Pfizer$574
- Novo Nordisk$541
- Johnson & Johnson$525
- plus $3K from 24 others
What the payments were for
- Consulting fees$1001%
- Food & beverage$7,11097%
- Education$1011%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 50 | $877 |
| Boehringer Ingelheim | 35 | $729 |
| GSK | 32 | $648 |
| Pfizer | 25 | $574 |
| Novo Nordisk | 29 | $541 |
| Johnson & Johnson | 25 | $525 |
| Lilly USA, LLC | 34 | $494 |
| AbbVie(2 entities) | 30 | $456 |
| Amgen(2 entities) | 16 | $363 |
| Merck | 19 | $281 |
| Novartis | 16 | $274 |
| Sanofi-aventis U.S. LLC | 14 | $270 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 11 | $215 |
| Teva Pharmaceuticals USA, Inc. | 11 | $180 |
| Astellas Pharma US Inc | 6 | $178 |
| Comsort, Inc | 1 | $100 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $95 |
| Hikma Pharmaceuticals USA | 5 | $81 |
| E.r. Squibb & Sons, L.L.C. | 5 | $67 |
| Esperion Therapeutics, Inc. | 3 | $60 |
| Ironwood Pharmaceuticals, Inc | 4 | $60 |
| Biohaven Pharmaceuticals, Inc. | 3 | $48 |
| Mylan Specialty L.p. | 3 | $45 |
| Paratek Pharmaceuticals, Inc. | 2 | $42 |
| Kowa Pharmaceuticals America, Inc. | 3 | $38 |
| Regeneron Healthcare Solutions, Inc. | 1 | $21 |
| Eyevance Pharmaceuticals LLC | 1 | $15 |
| Alfasigma USA, Inc. | 1 | $14 |
| Circassia Inc. | 1 | $11 |
| Mission Pharmacal Company | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SIVEXTRO$100
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.